Delve into the news for Cellebrite DI (NasdaqGS:CLBT) – the one-year price target has experienced a notable hike to 13.26 / share. This elevates it by a substantial 27.87% from the previous expectation marked at 10.37 way back on January 16, 2024.
Grasping the price target entails interpreting a concoction of varying analyst targets. The most recent figures span from a low at 12.12 to a high at 15.75 / share. The average price target signifies a progression of 13.24% from the most recent closing value reported at 11.71 / share.
Peering into Fund Sentiments
Take a peek into the perspective of 137 funds or institutions that have vested interests in Cellebrite DI. In the last quarter alone, these entities have grown by 24, clocking a remarkable 21.24% surge. The average portfolio weight dedicated solely to CLBT currently stands at 1.32%, indicating a surge of 67.60%. The total number of shares wielded by these institutions has skyrocketed by an impressive 51.51% in the past three months, now tallying 87,756K shares. The put/call ratio of CLBT is currently situated at 0.30, painting a vividly bullish outlook.
Exploring Shareholder Behavior
IGP Investments currently holds 21,088K shares, representing a significant 10.68% ownership of the company.
True Wind Capital Management secures 13,388K shares, denoting a 6.78% ownership stake in the company. This figure has remained static over the last quarter.
Clal Insurance Enterprises Holdings has a grasp on 7,086K shares, showcasing a stake of 3.59% ownership of the company. In the previous filing, the firm accounted for 6,571K shares, accounting for a surge of 7.27%. This quarter, the entity has upped its portfolio allocation in CLBT by a solid 16.87%.
Phoenix Holdings holds 4,055K shares, marking a 2.05% ownership fraction of the company. In its preceding report, the firm owned 6,024K shares, marking a decrease of 48.55%. The firm has slashed its portfolio allocation in CLBT by a substantial 53.69% this past quarter.
Nine Ten Capital Management wrangles 3,706K shares, commanding a 1.88% ownership. In the last filing, the firm listed 1,067K shares, marking a staggering 71.22% increase. The entity has expanded its portfolio allocation in CLBT by a remarkable 224.11% this quarter.
Insight into Cellebrite DI
Cellebrite emerges as a digital intelligence company hailing from Israel, offering tools to federal, state, and local law enforcement agencies, as well as enterprise corporations and service providers. Their offerings span the collection, review, analysis, and management of digital data.
(The company’s official description.)
Fintel surfaces as a comprehensive investing research platform catering to individual investors, traders, financial advisors, and small hedge funds. Our data tapestries across the globe encompass fundamentals, analyst reports, ownership data, fund sentiment, options sentiment, insider trading insights, options flow, unusual options trades, and beyond. Embedded within this trove are exclusive stock picks bolstered by advanced, backtested quantitative models aimed at magnifying profits.
Delve further into this captivating saga on Fintel’s platforms.
Examine not just facts and figures, but also sentiments and shifts. Dive into the collective wisdom of analysts and institutions as we decipher the rise of Cellebrite DI. Let the numbers tell their tale.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
